Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitelanthiopharma.com
CategoryBioTech
Phone31-50-363-5246
Emailinfo@lanthiopharm...
Employees

Offices

Netherlands
Nijenborgh 4
9747 AG Groningen
NLD
Groningen, NLD

Funding

TOTAL $6.19M
FUNDING TOTAL $6.19M
Series A, 11/2012
BioGeneration Ventures
INKEF Capital
€4.8M

Tags

Lanthio Pharma

Lanthio Pharma is a privately held drug discovery company that applies its proprietary lanthionine-peptide drug discovery technology LanthioPepTM for the generation of novel peptide therapeutics with increased resistance to peptidase degradation, high receptor specificity and increased intrinsic activity. Lanthio Pharma has generated stable, peptidase-resistant lanthionine peptides with highly specific agonistic activity for a number of GPCR targets, which is a focus area of the company.

Recent Milestones

Videos

Screenshots

Lanthio Pharma screenshot
Above: Lanthio Pharma
Uploaded: 11/29/12

Sources

  1. Lanthio Pharma Raises €4.8M in First Close of Series A funding (finsmes.com) [edit]
Edit This Page
Last Edited 3/29/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy